420 related articles for article (PubMed ID: 25380929)
1. Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen?
Wasilewski G; Przybylowski P; Janik L; Nowak E; Sadowski J; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2830-4. PubMed ID: 25380929
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory.
Przybylowski P; Malyszko J; Malyszko JS; Kobus G; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4263-6. PubMed ID: 21168679
[TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients.
Koc-Zorawska E; Przybylowski P; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013 Jun; 45(5):2009-12. PubMed ID: 23769096
[TBL] [Abstract][Full Text] [Related]
4. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
[TBL] [Abstract][Full Text] [Related]
5. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
[TBL] [Abstract][Full Text] [Related]
6. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
Hohage H; Brückner D; Arlt M; Buchholz B; Zidek W; Spieker C
Clin Nephrol; 1996 May; 45(5):342-4. PubMed ID: 8738668
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
8. High-performance Liquid Chromatography Measured Metabolites of Endogenous Catecholamines and Their Relations to Chronic Kidney Disease and High Blood Pressure in Heart Transplant Recipients.
Wasilewski G; Przybylowski P; Wilusz M; Sztefko K; Janik Ł; Koc-Żórawska E; Malyszko J
Transplant Proc; 2016 Jun; 48(5):1751-5. PubMed ID: 27496485
[TBL] [Abstract][Full Text] [Related]
9. Anemia is a predictor of outcome in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko J
Transplant Proc; 2009 Oct; 41(8):3228-31. PubMed ID: 19857717
[TBL] [Abstract][Full Text] [Related]
10. [Fatty acid profile in phospholipids fraction with regard to blood pressure control in the kidney transplant patients].
Wilusz M; Cieniawski D; Ignacak E; Bugajska J; Berska J; Bętkowska-Prokop A; Kużniewski M; Sułowicz W; Sztefko K
Przegl Lek; 2016; 73(9):621-6. PubMed ID: 29688661
[TBL] [Abstract][Full Text] [Related]
11. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.
Moes AD; Hesselink DA; van den Meiracker AH; Zietse R; Hoorn EJ
Am J Kidney Dis; 2017 Jun; 69(6):796-804. PubMed ID: 28259499
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
Bunke M; Ganzel B
J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive regimen and prevalence of chronic kidney disease in orthotopic heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko J
Med Sci Monit; 2010 Nov; 16(11):CR563-6. PubMed ID: 20980962
[TBL] [Abstract][Full Text] [Related]
14. Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients.
Malyszko J; Przybylowski P; Koc-Zorawska E; Iaina-Levin N; Sadowski J; Mysliwiec M; Malyszko JS
Transplant Proc; 2010 Dec; 42(10):4259-62. PubMed ID: 21168678
[TBL] [Abstract][Full Text] [Related]
15. Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients.
Przybylowski P; Malyszko J; Kozlowska S; Malyszko J; Koc-Zorawska E; Mysliwiec M
Transplant Proc; 2011 Dec; 43(10):3888-91. PubMed ID: 22172866
[TBL] [Abstract][Full Text] [Related]
16. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
Taegtmeyer AB; Crook AM; Barton PJ; Banner NR
J Am Coll Cardiol; 2004 Sep; 44(6):1254-60. PubMed ID: 15364328
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic disorders in renal transplant recipients].
Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
[TBL] [Abstract][Full Text] [Related]
18. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
19. Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1808-11. PubMed ID: 20620528
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.
Spagnoletti G; Citterio F; Favi E; Rossi E; Delreno F; De Santis I; Salerno MP; Gargiulo A; Castagneto M
Transplant Proc; 2009 May; 41(4):1175-7. PubMed ID: 19460509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
